A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants.

Trial Profile

A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Mar 2014

At a glance

  • Drugs Enterovirus A vaccine (Primary) ; Alum
  • Indications Enterovirus A infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 24 Jan 2013 Results published in The Lancet.
    • 28 Nov 2012 ClinicalTrials.gov record for extension study integrated (NCT01734408).
    • 28 Nov 2012 ClinicalTrials.gov record for extension study integrated (NCT01734408).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top